98232757 - CYTEGRITY

Information

• Trademark
• 98232757

• Source

• Serial Number

  98232757

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  October 20, 2023
  a year ago

• Transaction Date

  February 25, 2025
  13 days ago

• Status Date

  January 14, 2025
  a month ago

• Published for Opposition Date

  January 14, 2025
  a month ago

• Location Date

  December 24, 2024
  2 months ago

• Status Code

  686

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  HAHN, AMY

• Attorney Docket Number

  034845.Cyteg

  Attorney Name

  Scott D. Woldow

  Law Office Assigned Location Code

  L10

• Owners

  • CSL BEHRING GENE THERAPY, INC

Case File Statements

• GS0051: Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for medical use relating to gene therapy; gene therapy vectors for medical use
• GS0011: Cell lines, being cells, for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines for clinical laboratory use; cell lines for scientific research, namely, cell lines for gene expression and for the synthesis of biological compounds; cells for scientific, laboratory, or medical research, namely, cells for gene expression systems and for the synthesis of biological compounds; viral vectors for use in science and industry

Case File Event Statements

• 10/24/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/25/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/5/2024 - 9 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/13/2024 - 9 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/13/2024 - 9 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/13/2024 - 9 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/11/2024 - 6 months ago

  8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 12/11/2024 - 2 months ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/11/2024 - 2 months ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/17/2024 - 2 months ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/8/2025 - 2 months ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/14/2025 - a month ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/14/2025 - a month ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/11/2024 - 6 months ago

  7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 12/11/2024 - 2 months ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA